Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open Label Placebo Study to Assess Inhalation Profile with NEXThaler in COPD Patients
2013-000262-11Phase 2Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of beclometasone dipropionate + formoterol in chronic obstructive pulmonary disease (COPD), sponsored by Chiesi Farmaceutici S.p.A. Primary endpoint: Inspiratory profile through NEXThaler device. Started May 2013; status: completed.
02
Drugs
beclometasone dipropionate + formoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2013-000262-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000262-11.